C
CRSP
Crispr Therapeut
51.76
+2.06+4.14%After Hours: 51.69 -0.07 -0.14%19:41 04/08 EDT
OPEN/PREV CLOSE52.00/49.70
TODAY RANGE50.19-52.61
VOL1.72M
MARKET CAP4.97B
52 WEEK RANGE30.04-78.48
AVG VOL (3M)1.90M
% TURNOVER1.80%
TURNOVER--
P/E (TTM)-8.0030
% RANGE4.86%
EPS(TTM)-6.4676
P/E(FORWARD)-10.1215
P/B2.583
BVPS20.04
DIVIDEND--
P/S1,414.21
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP4.73B
SHARES OUTSTANDING95.99M
NEXT EARNINGS05/04-05/08
FREE FLOAT91.29M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·16m ago
Undercovered Dozen: CVR Energy, Greystone Housing, Conagra Brands, And More
Seeking Alpha·5d ago
Quant ratings on Cathie Wood's top holdings: TSLA, CRSP, AMD, and TEM
Seeking Alpha·04/01 16:43
A Turning Point For Crispr Therapeutics As Commercial Growth Accelerates
Seeking Alpha·03/31 12:30
I Expect Crispr Therapeutics To Break Out As 2026 Revenue Exceeds Expectations
TipRanks·03/30 13:35
Mizuho Securities Reaffirms Their Buy Rating on Crispr Therapeutics AG (CRSP)
TipRanks·03/26 17:50
Cathie Wood’s ARK Invest Dumps $2.1M Worth of META Shares; Stock Sinks
NASDAQ·03/20 11:58
Vertex Stock Falls 4.8% in a Month: Buying Opportunity or Red Flag?
TipRanks·03/17 10:56
Crispr Therapeutics price target raised to $110 from $105 at Piper Sandler
TipRanks·03/16 20:34
Crispr Therapeutics Completes $600 Million Convertible Notes Offering
Seeking Alpha·03/16 11:05
Cathie Wood's weekly recap: adds JOBY, CRSP, TEM, sells TER, TXG, CRCL
Same Industry
Name/Symbol
Change%
Price